We are Simbec-Orion. An international, full service, boutique CRO; growing by bringing together the best possible people, healthcare professionals and drug developers, from all areas of clinical development.
We focus on a defined series of core therapeutic areas, where we can make best use of our skills elegantly to design, execute and deliver our clients' clinical development needs.
We are making Simbec-Orion a highly respected and profitable boutique CRO. We do this by working for our clients with excellence, commitment and passion for our trade. We provide an environment in which our colleagues can continue to grow and develop.
Simbec-Orion was created in 2014 by the merger of Simbec Research, the specialist CRO in Early Stage Clinical Development and Orion Clinical, a specialist European Late Stage CRO to create an international, full service, boutique CRO.
We offer our clients:
A full spectrum of drug development services from first-in-human Phase I clinical studies through to pivotal Phase III studies and Phase IV post marketing studies.
Specialist expertise in oncology, rare and orphan diseases, respiratory, dermatology and infectious diseases & vaccines
In-depth experience of all drug types, dosage forms and delivery mechanisms.
Access to patient populations across Europe and North America.
A highly experienced First in Human (FiH) Phase I organisation, having successfully delivered over 1500 Phase I and IIa studies, all on a single, dedicated research campus with in-house access to central labs.
Full-service Phase I, II and Phase III studies, for companies looking for a committed CRO thinking like fellow drug-developers, offering specialist expertise in oncology, rare and orphan diseases, dermatology, respiratory and infectious diseases & vaccines.
Complete Bioanalytical and Pathology laboratory capabilities to support every aspect of your clinical development program, from Phase I to Phase IV.